PUNCTURENEEDLE

K963794 · Ferguson Medical · KNW · Mar 19, 1998 · Gastroenterology, Urology

Device Facts

Record IDK963794
Device NamePUNCTURENEEDLE
ApplicantFerguson Medical
Product CodeKNW · Gastroenterology, Urology
Decision DateMar 19, 1998
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 876.1075
Device ClassClass 2
AttributesTherapeutic

Intended Use

The PunctureNeedle device is intended for use in puncturing precise anatomical locations (including but not limited to cysts, lesions, fluid spaces, etc.) and aspirating or injecting various fluids or contents. The device may be utilized under MRI guidance.

Device Story

PunctureNeedle is a disposable needle for puncturing precise anatomical locations (cysts, lesions, fluid spaces) to aspirate or inject fluids. Device is compatible with MRI guidance. Primary innovation is use of titanium alloy components to reduce MRI artifacts compared to stainless steel needles. Used by clinicians in medical settings for diagnostic or therapeutic procedures.

Clinical Evidence

No clinical data provided; substantial equivalence based on design and material characteristics.

Technological Characteristics

Disposable aspiration/injection needle. Key material: titanium alloy for MRI compatibility (reduced artifact). Form factor: standard needle. No electronic or software components.

Indications for Use

Indicated for patients requiring puncture of anatomical locations, including cysts, lesions, or fluid spaces, for the purpose of aspiration or injection of fluids/contents. Suitable for use under MRI guidance.

Regulatory Classification

Identification

A gastroenterology-urology biopsy instrument is a device used to remove, by cutting or aspiration, a specimen of tissue for microscopic examination. This generic type of device includes the biopsy punch, gastrointestinal mechanical biopsy instrument, suction biopsy instrument, gastro-urology biopsy needle and needle set, and nonelectric biopsy forceps. This section does not apply to biopsy instruments that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0} FERGUSON MEDICAL 916-342-4133 FAX: 916-343-4541 MAR 19 1998 k963794 01 September 1996 # 510(k) SUMMARY The 510(k) summary information required by 21 CFR 807.92 is as follows: A. Classification name: Needle, aspiration and injection, disposable, or biopsy instrument, gastroenterology-urology. Common/usual name: Aspiration needle, puncture needle, probe needle, irrigation needle, injection needle, etc. Proprietary name: PunctureNeedle B. Substantial equivalence: Terumo (K760775), Wilson-Cook (K851953, K851957), Daum (K961185), and others. C. Device description: The PunctureNeedle is a standard needle to puncture precise anatomical locations and inject or aspirate various fluids or contents. D. Intended use: The PunctureNeedle is intended for use in puncturing precise anatomical locations (including but not limited to cysts, lesions, fluid spaces, etc.) and aspirating or injecting various fluids or contents. The 3407 Bay Avenue • Chico, California 95973 • USA {1} device may be utilized under MRI guidance. E. Technological characteristics: The PunctureNeedle is similar to predicate devices in its design, function, and intended use. The proposed device is different than many needles in that the PunctureNeedle device has components components manufactured of titanium alloy, which yields less artifact than stainless steel when utilized under magnetic resonance conditions. Submitted, FERGUSON MEDICAL Establishment Registration Number 2937794 Frank Ferguson Official Correspondent {2} DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 MAR 19 1998 Mr. Frank Ferguson Ferguson Medical 3407 Bay Avenue Chico, California 95973 Re: K963794 Trade Name: PunctureNeedle Regulatory Class: II Product Code: KNW Dated: December 27, 1997 Received: January 5, 1998 Dear Mr. Ferguson: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. {3} Page 2 - Mr. Ferguson This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, Stephen Rhodes for Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4} Page 1 of 1 ...v(k) Number (If known): K963794 Device Name: PunctureNeedle Indications For Use: The PunctureNeedle device is intended for use in puncturing precise anatomical locations (including but not limited to cysts, lesions, fluid spaces, etc.) and aspirating or injecting various fluids or contents. The device may be utilized under MRI guidance. (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Stephen Plurdo (Division Sign-Off) Division of General Restorative Devices 510(k) Number K963794 Prescription Use ☑ (Per 21 CFR 801.109) OR Over-The-Counter Use ☐ (Optional Format 1-2-96)
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%